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Aims: To investigate the consequences of improvement in the workplace environment over six decades
(1940–96) in asbestos miners and millers from a developing country (Brazil).
Methods: A total of 3634 Brazilian workers with at least one year of exposure completed a respiratory
symptoms questionnaire, chest radiography, and a spirometric evaluation. The study population was
separated into three groups whose working conditions improved over time: group I (1940–66, n = 180),
group II (1967–76, n = 1317), and group III (1977–96, n = 2137).
Results: Respiratory symptoms were significantly related to spirometric abnormalities, smoking, and
latency time. Breathlessness, in particular, was also associated with age, pleural abnormality and
increased cumulative exposure to asbestos fibres. The odds ratios (OR) for parenchymal and/or non-
malignant pleural disease were significantly lower in groups II and III compared to group I subjects (0.29
(0.12–0.69) and 0.19 (0.08–0.45), respectively), independent of age and smoking status. Similar results
were found when groups were compared at equivalent latency times (groups I v II: 30–45 years; groups II
v III: 20–25 years). Ageing, dyspnoea, past and current smoking, and radiographic abnormalities were
associated with ventilatory impairment. Lower spirometric values were found in groups I and II compared
to group III: lung function values were also lower in higher quartiles of latency and of cumulative exposure
in these subjects.
Conclusions: Progressive improvement in occupational hygiene in a developing country is likely to reduce
the risk of non-malignant consequences of dust inhalation in asbestos miners and millers.
A
sbestos inhalation has been frequently associated with
structural and respiratory functional abnormalities.1 2
Control of exposure is of paramount importance to
reduce its deleterious effects. Asbestosis still constitutes a
major occupational health problem, especially for developing
countries, such as Brazil, where effective control of exposure
has been achieved only recently.3 A number of previous
studies have shown that asbestos mining and milling
increases the probability of asbestosis and pleural abnorm-
alities, with variable consequences on lung function.4–9 Brazil
is the world’s fifth leading producer of asbestos. Large scale
mining and milling activities started in the country in the
early 1940s. A single company has been in charge of asbestos
exploration in Brazil: from 1940 to 1967 in the Northeast
State of Bahia and, thereafter, in the Central State of Goias.
According to reports from the company and the union
workers, a programme aiming to monitor exposure and
health was introduced in the Goias’ mine starting in 1967 (as
detailed in Methods). To the authors’ knowledge, no previous
study has specifically looked at the long term effects of
improving environmental work conditions in a large cohort of
miners and millers from a developing country. This commu-
nication, therefore, deals with the first epidemiological study
aimed to evaluate the relation between radiographic evidence
of parenchymal and/or pleural disease and clinical and lung
function abnormalities, as modulated by progressive
improvement in occupational exposure, in Brazilian chryso-
tile asbestos miners and millers.
METHODS
Study design and subjects
This was a retrospective study. The study population
consisted of all workers and ex-workers of a single asbestos
mining and milling company (Sociedade Mineradora de
Amianto SA) who had worked for at least one year for the
company. This timeframe was chosen because shorter periods
of time are rarely associated with development of a
measurable respiratory risk.10 From the start of the com-
pany’s operation (1940) to the date of study commencing
(1996), 6098 subjects were found to fulfil this criterion. A list
of these subjects was made available to the investigators by
the company. During a four year period, a multi-institutional
effort, which included local municipalities and union work-
ers, was responsible for recruiting the subjects who partici-
pated in the study.
Asbestos mining and milling in Brazil covers three time
periods: (a) from 1940 to 1967 in the Sa˜o Fe´lix mine (State of
Bahia, Northeast Region), where no measurements of
exposure and/or control of exposure were operational and
tremolite was found in association with chrysotile
(n=538);11 (b) from 1967 to 1976 in the Canabrava mine
(State of Goia´s, Central Region) where no evidence of
amphyboles has been found (n=2134);12 and (c) from
1977 to 1996 when routine fibre measurements and a
comprehensive programme of controlled chrysotile exposure
were operational in the Canabrava mine (n=3426). Based on
the differences in quality and intensity of asbestos exposure
in the three time periods listed above, the study population
was stratified into three historical groups (I, II, and III).
Subjects who started working in the Canabrava mine before
1977 were included in group II, irrespective whether they
remained working in the mine after this time.
Informed consent for participation in the study was
obtained from all subjects, and the study protocol was
approved by the Medical Ethics Committee of the Campinas
State University (UNICAMP), Sao Paulo, Brazil.
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Measurements
Occupational and smoking history
A standardised occupational history was administered by
interview, detailing the start and end of exposure, the specific
workplace(s), and the estimated level of exposure (groups I
and II, see below). ‘‘Latency’’ was defined as the time period
elapsed since the time of first exposure to the time of the
health examination. Subjects were also asked about their
smoking history, and were classified as never smokers, ex-
smokers (smoking cessation at least one year before
examination), and current smokers.
The presence of dyspnoea was recorded in all subjects by
means of a Medical Research Council (MRC) questionnaire
translated into Portuguese.13 In addition, presence of other
respiratory symptoms (wheezing, phlegm, and cough) was
also established.
Exposure
Because there were no systematic fibre measurements in the
plants before 1976, a subjective, logarithmic scale was
developed to estimate indices of dust exposure for subjects
in groups I and II. Fibre measurements performed before the
start of the exposure control programme were used to
establish three broad levels of workplace dustiness (mild=
from 0.3 to 3 fibres/cubic cm (cc), moderate= from 3 to 30.0
fibres/cc, and severe=more than 30 fibres/cc). These levels
were colour coded on a questionnaire as green, white, and
red, respectively. Subjects were asked to indicate the colour
type and intensity that corresponded best to the average level
of dust exposure in their workplaces, from ‘‘no dust at
all’’=dark green, to ‘‘very dusty’’ =dark red.14
After 1976 (group III), measurements of asbestos fibres in
the occupational setting were routinely performed (fig 1).
Airborne samples were obtained from different areas of
activity in the mining and milling processes, using a
constant-flow sampler. Fibre counting was performed
according to the National Institute of Occupational Safety
and Health standards: a membrane filter was used to collect
the fibres and the counting was done with a phase contrast
microscope.15 Briefly, the exposure control programme
included: the introduction of a widespread air filtering, dust
collection, humidification, use of individual protection
devices, and automatic handling and packing of the milled
asbestos. An index of the workers’ asbestos exposure was
calculated assuming that the cumulative amount of asbestos
exposure in the lungs was proportional to intensity and
duration of the inhalation ‘‘load’’ for each job ever held
(cumulative exposure in fibres/year/cc).
Radiographic evaluation
Standard high-kilovoltage, posteroanterior chest radiographs
were performed at a single centre before the physiological
evaluation. Radiographs were classified by three chest
physicians up to September 1999 (two B-readers and one
A-reader)—that is, each film was read by multiple readers.
After this date, one of the B-readers was replaced on the
panel by a radiologist with 18 years’ experience. The readers
were blinded to the group to which the worker belonged.
Radiographs were interpreted according to the International
Labour Office (ILO) Classification of Radiographs of
Pneumoconiosis.16 For the present study, parenchymal
opacities were reported if the ILO reading was 1/0 or more:
occasional disagreement was sorted out by consensus.
Recorded profusion readings were the median values.
Presence of pleural plaques was also established.
Spirometry
Spirometric tests were performed with a calibrated pneumo-
tacograph (Fleisch No. 3). The subjects completed at least
three acceptable maximal forced expiratory manoeuvres:
technical procedures, acceptability, and reproducibility cri-
teria were those recommended by the American Thoracic
Society.17 The following variables were recorded and
expressed as: body temperature, ambient pressure, saturated
with water vapour (BTPS): forced vital capacity (FVC, l),
forced expiratory volume in one second (FEV1, l), FEV1/FVC
ratio, and forced expiratory flow between 25% and 75% of the
FVC (FEF25–75%, l/s). Values were compared with those
predicted from Pereira et al for the adult Brazilian popula-
tion:18 these regression equations consider age, gender, and
height. In these equations, the limits for normality are
defined according to the one sided 95% confidence interval
around the predicted value. An obstructive ventilatory defect
was defined as a reduced FEV1 (below the lower limit of
normality) and FEV1/FVC ratio (,0.7), with FVC values
above the lower limit of normality. A restrictive ventilatory
defect was defined as reduced FVC with normal FEV1/FVC.
Data analysis
Analyses were performed with SPSS for Windows 10.0
statistical software package (SPSS Inc., Chicago, IL, USA).
Data for which the distribution was normal are reported as
mean values and standard deviations (SD). One way ANOVA
was used to determine differences in subjects separated by
groups of exposure: post-hoc Scheffe´ test was used when
appropriate. Non-paired Student’s t test was used to compare
groups of exposure at the equivalent latency times.
Differences in proportions were assessed by x2 tests.
Main messages
N The risk of non-malignant lung abnormalities and lung
function impairment declined significantly over time as
asbestos exposure was progressively reduced in
Brazilian mines and mills.
N The negative consequences of smoking were particu-
larly evident in the younger subjects who were the least
exposed.
N Respiratory symptoms were independently associated
with lung function impairment, current or past smoking,
higher cumulative exposure, longer latency time,
ageing, and pleural abnormality.
N Cumulative exposure, latency time, smoking and
combined pleural and parenchymal abnormalities
were independent predictors of lung function decline.
N The risk of an obstructive ventilatory defect was higher
in subjects presenting with combined parenchymal and
pleural alterations than those with isolated parenchy-
mal abnormalities.
Policy implications
N Progressive improvement in occupational hygiene in
mines and mills is likely to markedly reduce the risk of
non-malignant consequences of dust inhalation in
miners and millers exposed mainly to chrysotile.
N Asbestos workers with combined pleural and parenchy-
mal abnormalities should be evaluated for early
detection of lung function impairment.
N Large scale anti-smoking strategies are warranted in
asbestos mines and mills.
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Stepwise multiple logistic regression analysis was per-
formed with clinical, radiographic, and lung function
abnormalities as the dependent variables. Interaction terms
between the independent variables were also considered for
model inclusion. Parameters known to be associated with the
outcomes of interest (latency and smoking) remained in the
final model at a level of significance of 0.15; for the other
variables, a p value of 0.05 was used. Considering the high
degree of collinearity between age and most of the
variables of interest, this parameter was allowed to remain
in the final models independently of its level of statistical
significance.
The effect of exposure group, cumulative exposure, and
latency time on the spirometric variables were analysed using
a modified life table procedure. In this method, the
cumulative ‘‘survival’’ of spirometric scores was compared
using the Wilcoxon test.19 A backward stepwise linear
regression procedure was also used for analysing the
relation of the spirometric variables to latency, cumulative
exposure, smoking (pack-years), and radiographic abnorm-
alities. Probability of type I error was established at 0.05 for
all tests.
Informed consent for participation in the study was
obtained from all subjects, and the study protocol was
approved by the Medical Ethics Committee of the Campinas
State University (UNICAMP), Sao Paulo, Brazil.
RESULTS
Population characteristics
From the 6098 eligible subjects, 433 (7.1%) were found to be
dead (148, 184, and 101 subjects for groups I, II, and III,
respectively); 3634 of the remaining 5665 were actually
examined (64.1%). The rate of recruitment success varied
between the different groups: group I=46.1% (180/390
alive), group II=67.5% (1317/1950), and group III=64.2%
(2137/3325) (table 1).
The demographic and occupational variables differed
significantly among the groups. Thus, group III subjects
were younger and presented with a shorter latency than
their counterparts of groups I and II (table 1); the median
values for latency time were: 42.5 years, 24.8 years, and
18.7 years, for groups I to III, respectively. Higher cumulative
exposure was also found in group I subjects compared to
groups II and III; the median values for cumulative exposure
for groups I to III were: 51.2, 20.2, and 2.4 fibre/y/cc,
respectively.
Clinical findings
Current or past smoking history was reported by 75.6% of
group I subjects (table 1): 18.9% (34/180) of these patients
smoked more than 50 pack-years compared to 7.0% (92/
1317) and 2.7% (58/2137) of group II and III subjects. There
was a significant association of smoking with obstructive
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Figure 1 Annual decline on fibre concentrations in the Canabrava mine (Central Brazil) since 1976. Concentration readings were obtained at
different locations in the mine.
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Table 1 Population characteristics according to groups of asbestos exposure
Variables Group I (n = 180) Group II (n = 1317) Group III (n = 2137)
Demographic/anthopometric
Age (years) 64.9¡8.4 51.1¡7.9* 41.3¡9.5**
Body mass index (kg/m2) 25.3¡4.1 26.3¡4.2 25.7¡3.9
Occupational exposure
Latency (years) 43.7¡7.0 25.9¡3.6* 15.9¡5.8**
Exposure (years) 12.9¡10.7 10.1¡7.2* 7.5¡3.2**
Cumulative exposure (fibre/y/cc) 109.1¡141.9 39.4¡50.4* 4.3¡5.9**
Clinical findings
Current or past smoking (%) 75.6 63.7 49.6
Smoking (pack-years) 33.1¡56.5 14.5¡22.4* 8.4¡17.0**
Symptom prevalence
Dyspnoea (%) 17.8 30.3 15.3
Wheezing (%) 7.8 15.9 6.9
Cough (%) 16.1 22.4 10.8
Phlegm (%) 10.6 14.1 7.5
Radiographic abnormalities
Parenchymal (1/0 or greater, %) 9.5 2.7 0.8
1/0 (%) 5.0 1.5 0.6
1/1 (%) 3.9 0.5 0.2
1/2 or greater (%) 0.6 0.7 –
Pleural (%) 16.1 4.0 1.7
Pleural and/or parenchymal (%) 22.2 6.0 2.5
Lung function abnormalities
FVC (% pred) 94.4¡17.3 102.5¡17.41* 106.0¡14.9**
FEV1 (% pred) 91.0¡20.0 97.2¡18.2* 100.7¡15.7**
FEV1/FVC (%) 70.1¡7.1 72.2¡7.3* 74.2¡7.1**
FEF25–75% (% pred) 77.2¡39.3 85.8¡39.1* 83.0¡38.8
Abnormal spirometry (%) 29.8 24.5 20.0
Obstructive (%) 82.3 80.1 88.8
Restrictive (%) 11.7 18.6 9.9
Combined (%) 7.0 1.3 1.3
Number of recruited/eligible subjects alive: group I = 180/390 (46.1%); group II = 1317/1950 (67.5%); and
group III = 2137/3325 (64.2%).
p,0.05: *group II v I and III; **group III v I and II (ANOVA).
 x2 analysis.
Table 2 Final logistic regression models for symptoms
Logit coefficient (SE) Odds ratio (95% CI)
Dyspnoea*
Restrictive defect 0.94 (0.21) 2.57 (1.68 to 3.91)
Obstructive defect 0.59 (0.10) 1.80 (1.48 to 2.20)
Current or past smoking 0.51 (0.09) 1.67 (1.39 to 1.99)
Pleural abnormality 0.41 (0.21) 1.50 (1.01 to 2.21)
Cumulative exposure >10 fibres/y/cc 0.38 (0.09) 1.47 (1.23 to 1.75)
Age over 50 years 0.36 (0.12) 1.43 (1.11 to 1.84)
Constant 22.03 (0.08)
Wheezing
Obstructive defect 0.95 (0.12) 2.59 (2.04 to 3.30)
Restrictive defect 0.92 (0.26) 2.52 (1.49 to 4.27)
Current or past smoking 0.57 (0.12) 1.77 (1.38 to 2.25)
Latency over 20 years 0.03 (0.006) 1.03 (1.02 to 1.04)
Constant 23.53 (0.16)
Cough
Restrictive defect 0.93 (0.23) 2.54 (1.59 to 4.05)
Obstructive defect 0.81 (0.11) 2.26 (1.82 to 2.80)
Current or past smoking 0.48 (0.10) 1.63 (1.32 to 2.00)
Latency over 20 years 0.04 (0.005) 1.04 (1.03 to 1.05)
Constant 23.23 (0.14)
Phlegm
Obstructive defect 0.87 (0.12) 2.40 (1.87 to 3.07)
Current or past smoking 0.74 (0.13) 2.10 (1.62 to 2.72)
Restrictive defect 0.70 (0.29) 2.01 (1.13 to 3.59)
Latency over 20 years 0.03 (0.006) 1.03 (1.02 to 1.04)
Constant 23.72 (0.17)
*MRC questionnaire.13
The following variables were considered for model inclusion: age (.50 years), group of exposure, obstructive and
restrictive impairments, radiographic abnormalities, cumulative exposure (>10 fibres/y/cc), latency (>20 years),
and smoking (current or past).
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impairment and dyspnoea in all groups (p , 0.05, x2 test,
data not shown).
Twenty one per cent of the workers reported breathlessness
on daily activities.12 The prevalence of dyspnoea was lowest in
group III (table 1). This symptom was independently
associated with lung function impairment (both restrictive
and obstructive), current or past smoking, cumulative
exposure (>10 fibre/y/cc), and age over 50 years (p,0.05,
Table 2). In addition, pleural abnormalities were independent
predictors of subjective impairment (table 2).
Wheezing, cough, and phlegm were found in 10.9%, 14.9%,
and 10.1% of the groups, respectively (data not shown). As
with dyspnoea, prevalence of these symptoms tended to be
lower in group III, compared to groups I and II (table 1). As
shown in table 2, lung function impairment (both restrictive
and obstructive), current and past smoking, and latency time
(over 20 years), but not radiographic abnormalities, were
independently associated with these specific outcomes
(p , 0.01).
Radiographic abnormalities
Parenchymal or pleural abnormalities16 were found in 1.9%
and 3.3% of the workers and the lesions were concomitantly
found in 4.7% of the population. The prevalence of these
abnormalities was significantly higher in group I subjects
(table 1). Most subjects presented with only minor x ray
alterations, even in group I subjects (table 1).
Age over 50 years was a strong independent predictor of
radiographic abnormalities, especially for parenchymal
alterations (p , 0.01). Odds ratios for pleural and combined
(pleural and/or parenchymal) abnormalities were signifi-
cantly lower in groups II and III compared to group I subjects
(table 3). Cumulative exposure equal or greater than 10
fibres/y/cc and current or previous smoking increased the
event probability in all groups (table 3). Interestingly, there
were interaction effects of cumulative exposure with group II
and of smoking with group III for the prediction of pleural
and/or parenchymal abnormalities. Thus, a higher cumula-
tive exposure and current or previous smoking increased the
risk of mixed abnormalities in group II and III subjects,
respectively (table 3).
Considering the large differences on latency time among
the three groups (table 1), we also compared the groups at
similar latency ranges (groups I v II= 30–45 years and group
II v III=20–25 years). As shown in table 4, the prevalence of
parenchymal or mixed (pleural and/or parenchymal)
abnormalities were higher in group I compared to group II.
Similarly, group II subjects presented with higher prevalence
of pleural or mixed abnormalities than group III subjects
with similar latency times (table 4).
Lung function abnormalities
One hundred and twenty one tests did not meet our quality
criteria17 and therefore they were not included in the study.
Spirometric abnormalities were found in 776 subjects
(24.7%), with most of them depicting only mild obstructive
impairment (data not shown). Table 5 shows that past and
current smoking and radiographic abnormalities were asso-
ciated with increased risk of obstructive defects; interestingly,
however, smoking was related to a reduced risk of restrictive
abnormalities. Ageing and dyspnoea were also independently
associated with ventilatory impairment (table 5). Presence of
combined pleural and parenchymal abnormalities did not
enhance the likelihood of restrictive impairment compared to
pleural abnormality alone (OR 2.20 (95% CI 1.55 to 3.11) v
3.64 (95% CI 1.86 to 7.10), respectively).
Although the mean spirometric values were close to
normality in all groups (tables 1 and 4), the life table
analysis showed significant differences between exposure
groups. FVC scores were found to be lower in group I,
especially when compared to group III subjects (fig 2A). A
further intra-group analysis showed a significant effect of
cumulative exposure and latency in groups I and II.
Therefore, the higher quartiles of exposure and latency time
exhibited lower spirometric scores compared to the inter-
quartile range or lower quartiles in these groups (p , 0.05).
Data for FVC values are shown in figs 2B–D: similar results
were found in relation to FEV1, FEV1/FVC, and FEF25–75%
(not shown).
We also sought to determine the independent predictors of
lung function impairment when the spirometric responses
were expressed as continuous variables (% predicted). As
shown in table 6, latency over 25 years, current or past
smoking, combined pleural and parenchymal abnormalities,
and increased cumulative exposure were related to reduced
spirometric values (p , 0.05).
Table 3 Final logistic regression models for radiographic abnormalities
Logit coefficient (SE) Odds ratio (95% CI)
Parenchymal abnormalities
Age .50 years 1.86 (0.25) 6.47 (3.89 to 10.75)
Cumulative exposure >10 fibres/y/cc 1.10 (0.28) 3.02 (1.72 to 5.31)
Current or past smoking 0.39 (0.27) 1.48 (0.86 to 2.56)
Constant 25.30 (0.29)
Pleural abnormalities
Age .50 years 1.24 (0.24) 3.48 (2.16 to 5.60)
Cumulative exposure >10 fibres/y/cc 0.36 (0.24) 1.44 (0.89 to 2.33)
Current or past smoking 0.31 (0.21) 1.36 (0.90 to 2.06)
Group II* 20.70 (0.28) 0.49 (0.28 to 0.86)
Group III* 21.10 (0.36) 0.33 (0.16 to 0.67)
Constant 23.24 (0.38)
Pleural and/or parenchymal abnormalities
Age .50 years 1.37 (0.20) 3.95 (2.66 to 5.87)
Group II* and cumulative exposure >10 fibres/y/cc 0.75 (0.44) 2.12 (0.88 to 5.10)
Group III* and current or past smoking 0.73 (0.37) 2.07 (0.99 to 4.30)
Cumulative exposure >10 fibres/y/cc 0.19 (0.31) 1.21 (0.66 to 2.22)
Current or past smoking 0.09 (0.21) 1.10 (0.72 to 1.68)
Group II* 21.24 (0.45) 0.29 (0.12 to 0.69)
Group III* 21.66 (0.42) 0.19 (0.08 to 0.45)
Constant 22.62 (0.39)
*Compared to Group I.
The following variables were considered for model inclusion: age (.50 years), group of exposure, obstructive and
restrictive impairments, cumulative exposure (>10 fibres/y/cc), latency (>20 years), and smoking (current or
past).
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DISCUSSION
The present investigation examined the subjective and
objective consequences of progressive improvement in work-
place conditions in 3634 Brazilian asbestos miners and
millers, the largest evaluation ever performed in this work-
force. The main findings of this study were as follow: (1)
respiratory symptoms were independently associated with
lung function impairment (both obstructive and restrictive),
current or past smoking, higher cumulative exposure, longer
latency time, ageing, and pleural abnormality on chest x ray;
(2) prevalence of radiographic abnormality was considerably
lower in subjects who worked under improved environmental
conditions (groups II and III compared to group I),
independent of age and smoking status; and (3) the lung
function consequences of asbestos exposure were signifi-
cantly less frequent in group III (not exposed to amphibole
containing chrysotile) compared to group I (exposed).
Asbestos mining and milling have well characterised
relations with a number of hazards for the respiratory
system,4–9 20–23 and it is intuitive to consider that reduction
in exposure would be related to less morbidity. However, few
studies have examined the effects of changing workplace
conditions on the respiratory health of a large number of
asbestos workers exposed primarily to chrysotile in a
developing country. In our study, we had access to the large
database of the single company responsible for asbestos
mining and milling in Brazil since the early 1940s. This
allowed us to evaluate the historical trends of changes in
estimated exposure and the risk of development of lung
structural and lung function impairment. Our results show
that following the establishment of controlled exposure
conditions there were reduced rates of non-malignant
respiratory morbidity related to asbestos mining and milling.
Clinical consequences of asbestos exposure in mining
and milling
In the present study, the prevalence of respiratory symptoms
was relatively low, with most subjects reporting mild
dyspnoea. Chronic breathlessness was related to either
parenchymal or pleural abnormalities. However, only pleural
abnormality was retained in the final model (table 2). In
contrast, Lilis and colleagues24 found that only combined
disorders were predictive of subjective impairment.
Differences in population characteristics, in the extent of
radiographic changes, and in the circumstances of exposure
(insulators versus miners and millers) may explain these
inter-study discrepancies.
A particularly interesting finding was the strong associa-
tion among all of the respiratory symptoms with objective
evidence of lung function impairment (obstructive and
restrictive defects). Another important predictor was current
or previous cigarette smoking, a finding in keeping with the
studies of Quebec chrysotile miners and millers.5 6 21 These
findings suggest that symptoms, a subjective measure of
impairment, are useful outcomes in large epidemiological
evaluations of asbestos exposed workers.25–28 Whether the
reported symptoms can be directly attributed to asbestos
exposure, however, remains a topic of controversy. Of
interest, is that cumulative exposure was retained in the
final models only for dyspnoea, a cardinal symptom of
asbestosis (table 2). In addition, the significant effect of
smoking in explaining the radiographic abnormalities in the
younger workers (group III) (table 2) underscores the
importance of establishing active anti-smoking strategies
among current asbestos miners and millers in Brazil.
Radiographic changes associated with asbestos
mining and mill ing
The risk of development of radiographic abnormality was
significantly increased in subjects with higher exposure and
longer latency (group I) compared to groups II and III
(table 3). In addition, the determinants of those outcomes
differed significantly between study groups. Thus, the risk of
pleural and/or parenchymal abnormalities were increased in
group III subjects with a history of smoking and in group II
subjects with high levels of cumulative exposure (table 3).
Surprisingly, cumulative exposure did not increase the
likelihood of lung function and radiographic abnormalities in
group I. This finding was probably related to the homo-
geneously high level of exposure in these subjects. An
alternative explanation may be the presence of tremolite in
this mine, independent of the high exposure levels. In
addition, we could not rule out the presence of a ‘‘survival’’
effect in the present study—that is, those subjects who were
alive at the time of examination would be more resistant to
the deleterious effects of asbestos inhalation (see also Study
limitations).
Table 4 Comparison between groups of exposure at equivalent latency times from the
start of exposure to health examination
Variables
30–45 years latency 20–25 years latency
Group I
(n = 107)
Group II
(n = 217)
Group II
(n = 713)
Group III
(n = 713)
Demographic/anthopometric
Age (years) 61.5¡7.3 56.0¡7.1* 49.1¡7.8 47.3¡7.3*
Body mass index (kg/m2) 25.3¡4.3 26.3¡4.5* 26.1¡4.1 26.2¡4.0
Occupational exposure
Exposure (years) 10.7¡10.4 10.2¡8.8 10.1¡6.1 9.7¡6.8
Cumulative exposure (fibre/y/cc) 97.3¡124.4 63.8¡78.6* 121.5¡79.3 92.9¡66.3*
Radiographic abnormalities
Parenchymal (%) 10.3 3.7  2.4 1.3
Pleural (%) 11.2 6.9 4.6 2.0 
Pleural and/or parenchymal (%) 18.7 9.2  5.6 3.1 
Lung function abnormalities
FVC (% pred) 97.5¡17.2 100.2¡17.3 103.4¡16.9 104.9¡15.6*
FEV1 (% pred) 93.9¡19.5 94.5¡20.0 98.2¡18.1 99.2¡17.1
FEV1/FVC (%) 74.8¡7.2 74.7¡7.5 76.9¡7.8 77.1¡7,2
FEF25–75% (% pred) 81.7¡40.1 82.3¡40.1 88.5¡37.5 83.8¡40.1*
p,0.05: *non-paired t test; x2 analysis (Pearson).
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We were also able to confirm some previous reports that
pleural abnormalities per se are associated with respiratory
symptoms and lung function impairment.22 24 25 29 Although
in the past pleural abnormalities, particularly pleural plaques,
have often been considered as functionally silent, we found
that presence of combined pleural and parenchymal abnorm-
alities were better predictors of impairment than isolated
parenchymal abnormalities. Considering that we did not
Table 5 Final logistic regression models for lung function impairment
Logit coefficient (SE) Odds ratio (95% CI)
Obstructive defect
Parenchymal and pleural abnormalities 0.79 (0.17) 2.20 (1.55 to 3.11)
Dyspnoea* 0.53 (0.10) 1.69 (1.39 to 2.06)
Current or past smoking 0.44 (0.09) 1.56 (1.30 to 1.86)
Age .50 years 0.42 (0.13) 1.52 (1.18 to 1.95)
Constant 21.96 (0.07)
Restrictive defect
Pleural abnormality 1.18 (0.35) 3.27 (1.63 to 6.56)
Dyspnoea* 0.83 (0.21) 2.29 (1.51 to 3.49)
Age .50 years 0.32 (0.28) 1.38 (0.79 to 2.40)
Current or past smoking 20.70 (0.20) 0.49 (0.33 to 0.74)
Constant 23.47 (0.14)
*MRC questionnaire.13
The following variables were considered for model inclusion: age (.50 years), radiographic abnormalities,
cumulative exposure (>10 fibres/y/cc), latency (>20 years), symptoms, and smoking (current or past).
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Figure 2 Differences in cumulative probability of individual scores of forced vital capacity (FVC, % predicted). (A) Inter-group analysis. (B–D) Within-
group effect of cumulative exposure (for groups I, II, and III, respectively). Notes: (A) group I6III (x2 = 125.18, p,0.00001); group I6II (x2 = 37.43,
p,0.00001); group II6III (x2 = 48.02, p,0.00001); (B) upper quartile6 lower quartile (x2 = 4.89, p = 0.0270); upper quartile6 interquartile range
(x2 = 6.72, p,0.0095); interquartile range6 lower quartile (x2 = 0.10, p.0.05); (C) upper quartile6 lower quartile (x2 = 9.66, p,0.01); upper
quartile6 interquartile range (x2 = 7.72, p,0.01); interquartile range6 lower quartile (x2 = 0.84, p.0.05); (D) Wilcoxon test (p.0.05).
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differentiate pleural plaques from diffuse pleural thickening,
we could not identify the precise structural basis of these
intriguing findings.
Lung function findings
In our study, lung function indexes in group I and II subjects
were consistently lower than in group III subjects (fig 2A)—
although most subjects did not present abnormal tests results
(at least as assessed by mean values expressed as % of
predicted). This was also true when we considered the
quartiles of exposure and latency time (fig 2B–D). Recently,
Algranti and co-workers,30 using a similar approach, also
found a significant effect of exposure on lung function levels
in Brazilian asbestos-cement workers. These data highlight
the relevance of analysing large epidemiological data using
more sensitive statistical procedures to unravel the effects of
exposure on lung function.19
Interestingly, we found parenchymal and pleural abnorm-
alities to be associated with an obstructive ventilatory defect,
independent of smoking (table 5). We interpret these results
as indication that increased dust exposure—as suggested by
higher prevalence of pleural plaques—can be related to
airways disease. In fact, studies involving a large cohort of
Canadian miners and millers found a substantial increase in
‘‘bronchitis’’ with chrysotile exposure and smoking.4 5
Moreover, Kilburn and Warshaw27 found evidences of airflow
limitation and air trapping 20 years after the cessation of
exposure in asbestos workers who never smoked. Whether
this can be directly attributed to asbestos fibres (due to
peribronchiolar infiltrates and/or fibrosis—that is, asbestos
small airways disease), the level of non-specific dust or other
contaminants remains to be determined.
Study limitations
The retrospective nature of the exposure evaluation and the
chronological definition of the study groups implied that age
and latency time—two well-known confounding factors—
were dissimilar among the three groups. Thus, group III
subjects were younger and presented with lower latency time
than their counterparts of groups I and II (table 1). However,
at the time of the present evaluation, more than half of group
III workers already had a latency time of at least 20 years. In
fact, a post hoc analysis with the subjects grouped according
to equivalent latency times showed that group I subjects had
higher prevalence of radiographic abnormalities than group
II; in addition, group III subjects presented with less
abnormalities than group II workers with similar latency
(table 4). Considering, however, that there have been reports
of a significant longitudinal decline in lung function in other
asbestos exposed workforces,10 31 32 prospective evaluations of
the present study population should be undertaken to
improve the inter-group comparability.
While ideally a reference (non-exposed) population should
have been studied in parallel with the present study
population, in practice identification of such a reference
population is difficult because of the ‘‘healthy’’ worker effect.
In fact, the study design also means that this phenomenon
could not be ruled out as a cause of selection bias: we were
unable to evaluate 35.9% of the target population, particu-
larly in group I. In this context, it should be recognised that
the impact of a survival effect would be more prominent in
this group which have been more heavily exposed to asbestos
(table 1). Therefore, we may have even underestimated the
true prevalence of radiographic abnormalities in the older
workers.
Also important is that asbestos exposure in the older
groups was estimated using a subjective method. Therefore,
we cannot rule out that these workers may have over-
estimated the degree of dustiness in their workplace, though
photographic records support their estimates. We may also
have underestimated the prevalence of morphological and
functional abnormalities since the more sensitive imaging
and lung function techniques were not used (for example,
high resolution computed tomography and lung diffusion
capacity).
Unfortunately, we were also unable to assess the asbestos
related mortality in this sample: death certificates are
notoriously imprecise in remote areas of Central Brazil and
there was no systematic recording of the whereabouts of the
ex-workers. Finally, it is important to emphasise that our
results should not be extrapolated for asbestos related
malignant disease.
Conclusions
We conclude that improvements over time in workplace
conditions are associated with a significant decrease in the
risk of non-malignant abnormalities in Brazilian chrysotile
asbestos miners and millers. Our data are particularly
relevant for developing countries where asbestos extraction
is performed on a large scale and healthcare resources are
scarce. The present results, however, should be further
confirmed in prospective and controlled studies, including
in the present study population.
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Table 6 Multiple regression analysis of lung function variables
Cumulative exposure
(fibres/y/cc) Latency time (years) Smoking (pack-years)
Pleural and
parenchymal
abnormalities Constant R2 (SEE)
FVC (% pred) 20.0161 (0.006) 20.260 (0.025) NS 26.599 (1.276) 110.36 (0.72) 0.04 (15.8)
FEV1 (% pred) NS 20.232 (0.034) 20.0537 (0.013) 29.310 (1.347) 104.9 (0.72) 0.05 (16.7)
FEV1/FVC (%) NS 20.196 (0.003) 20.0128 (0.001) 20.485 (0.127) 85.7 (0.07) 0.04 (12.3)
FEF25–75% (% pred) NS NS 20.0711 (0.028) 211.678 (3.098) 85.2 (0.73) 0.57 (7.0)
R2, coefficient of determination; SEE, standard error of the estimate; NS, non-significant.
(–) indicates that the independent variable did not remain in the final model.
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